Canada· CA-DIN-02248302

MULTIHANCE

A gadobensäure product containing gadobenate dimeglumine, registered in Canada by BRACCO IMAGING CANADA. The same ATC class is registered in 9 of our 19 countries.

ATC V08CA08

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedMULTIHANCEATCV08CA08REGISTER NO.CA-DIN-02248302PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Gadobensäure is registered in 9 of 19 countries.

Countries holding a registration under ATC V08CA08 (gadobensäure), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 5 of them publish a price we can compare per daily dose

Gadobensäure · ATC V08CA08

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
GADOBENATE DIMEGLUMINE
Manufacturer
BRACCO IMAGING CANADA
Country
Canada (CA)
ATC code
V08CA08
ATC class
Gadobensäure
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Gadobensäure in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gadobensäure products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Multihance
  • Belgium · Multihance
  • Czechia · Multihance
  • Germany · Multihance
  • Denmark · Multihance
  • Spain · Multihance
  • Finland · Multihance
  • France · Multihance
  • United Kingdom (Northern Ireland) · Multihance
  • Greece · Multihance
  • Croatia · Multihance
  • Hungary · Multihance
  • Ireland · Multihance
  • Italy · Multihance
  • Luxembourg · Multihance
  • Netherlands · Multihance
  • Norway · Multihance
  • Poland · Multihance
  • Portugal · Multihance
  • Romania · Multihance
  • Sweden · Multihance
  • Slovenia · Multihance

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/59563b4b-507c-4835-ab67-842f59fa2580
GET /v1/drugs/59563b4b-507c-4835-ab67-842f59fa2580?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02248302",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V08CA08",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "72643",
  "strengths": [
    "529 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "GADOBENATE DIMEGLUMINE"
  ],
  "product_categorization": null
}

See everything about gadobensäure.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.